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The virulence determinants of uropathogenic Escherichia coli have been studied extensively over the years,
but relatively little is known about what differentiates isolates causing various types of urinary tract infections.
In this study, we compared the genomic profiles of 45 strains from a range of different clinical backgrounds,
i.e., urosepsis, pyelonephritis, cystitis, and asymptomatic bacteriuria (ABU), using comparative genomic
hybridization analysis. A microarray based on 31 complete E. coli sequences was used. It emerged that there
is little correlation between the genotypes of the strains and their disease categories but strong correlation
between the genotype and the phylogenetic group association. Also, very few genetic differences may exist
between isolates causing symptomatic and asymptomatic infections. Only relatively few genes that could
potentially differentiate between the individual disease categories were identified. Among these were two
genomic islands, namely, pathogenicity island (PAI)-CFT073-serU and PAI-CFT073-pheU, which were signif-
icantly more associated with the pyelonephritis and urosepsis isolates than with the ABU and cystitis isolates.
These two islands harbor genes encoding virulence factors, such as P fimbriae (pyelonephritis-associated
fimbriae) and an important immunomodulatory protein, TcpC. It seems that both urovirulence and growth
fitness can be attributed to an assortment of genes rather than to a specific gene set. Taken together,
urovirulence and fitness are the results of the interplay of a mixture of factors taken from a rich menu of genes.
Urinary tract infection (UTI) is one of the most common
bacterial infections of humans and a major cause of morbidity.
It is estimated that there are more than 10 million cases in
Western Europe per year. UTI also accounts for 25 to 40% of
all nosocomial infections, making these infections an impor-
tant medical and financial burden on health care systems (16,
37). UTI usually starts as a bladder infection but can, depend-
ing on the bacterial strain, ascend to the kidneys and may
ultimately can result in renal failure or dissemination to
the blood. UTI is classified into disease categories according to
the focal point and the severity of infection: bacteriuria (the
urine), cystitis (the bladder), pyelonephritis (the kidneys), and
urosepsis (the blood). Growth in urine in the absence of symp-
toms is called asymptomatic bacteriuria (ABU). ABU resem-
bles a commensal-like carrier state, which often goes unnoticed
by the patient. UTIs primarily affect women and girls; 40 to
50% of adult women will experience at least one UTI episode
during their lifetime (8, 34).
Escherichia coli is the most important etiological agent of
UTIs and is associated with more than 80% of all such infec-
tions (36). E. coli strains are usually associated with a com-
mensal lifestyle in the gastrointestinal tract. However, some
strains have acquired the ability to cause disease. Intestinal
pathogenic E. coli can cause a range of intestinal disorders,
while extraintestinal pathogenic E. coli (ExPEC) causes a va-
riety of extraintestinal infections, such as urinary tract infec-
tions, septicemia, neonatal meningitis, and infections of the
respiratory tract (19). Unlike diarrheagenic strains, ExPEC
strains do not cause disease in the intestinal tract; however,
they are normally excellent long-term colonizers of the intes-
tine (17). ExPEC strains constitute about 20% of the E. coli
strains of the human fecal flora in healthy individuals (35). It is
generally believed that strains infecting the urinary tract orig-
inate from the fecal flora. E. coli is also found in the vagina in
about 20% of healthy women (8, 25).
The phenotypic profile of a strain is reflected in the genome
content. The genomes of E. coli strains vary in size from about
4.6 to 5.6 Mb. They have mosaic structures and consist of a
conserved core of genes plus a flexible gene pool that is strain
specific. The flexible gene pools typically comprise genes en-
coding niche-specific fitness factors and also, in the case of
pathogenic strains, virulence factors (6). The genetic determi-
nants of uropathogenic E. coli (UPEC) have been studied
extensively, and a range of virulence and fitness factors, includ-
ing various types of adhesins, toxins, and iron uptake systems,
have been implicated in pathogenesis. However, the specific
factors that differentiate strains of E. coli that cause different
types of UTI remain unclear. While bacterial strain variation
most likely plays an important part in determining the outcome
of any initial colonization, individual patient parameters are
also important. Understanding the genetic basis for pathoge-
nicity in ExPEC, especially with regard to genetic determinants
associated with different types of UTIs, will be important in the
development of preventive measures.
Recently, we designed a multigenome E. coli microarray for
comparative genomic hybridization (CGH) of E. coli isolates
from diverse origins (40). The array was based on 31 complete
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E. coli genomic sequences representing a wide range of patho-
genic, as well as commensal, isolates. The diverse nature of the
CGH array makes it an excellent tool for studying the genomic
contents of unsequenced E. coli isolates. Here, we employed
this array to compare a range of E. coli strains causing urinary
tract infections in an attempt to further discriminate between
isolates causing different types of UTI.
MATERIALS AND METHODS
Bacterial strains. The E. coli strains included in the study are listed in Table
1. The ABU isolates are all confirmed ABU strains, i.e., they were isolated from
the urine of asymptomatic women with bacteriuria, defined as two consecutive
voided urine specimens with isolation of the same bacterial strain in counts of
105 CFU/ml. The cystitis and pyelonephritis strains have been isolated in
monocultures from the urine of patients diagnosed with acute cystitis and acute
pyelonephritis, respectively, all at Hvidovre Hospital (Denmark). The urosepsis
isolates were cultured from the blood of patients suffering from UTI-derived
sepsis at the Princess Alexandra Hospital (Brisbane, Australia). All strains were
grown in modified LB medium (39) prior to genomic-DNA isolation and phe-
notypic characterization. Three well-characterized strains commonly reported in
the literature, namely, CFT073 (pyelonephritis), 83972 (ABU), and Nissle 1917
(commensal/probiotic; Mutaflor, Ardeypharm GmbH), were included as refer-
ence strains for comparative purposes.
Microarray design and sample preparation. The detailed design of the custom
microarray has been described elsewhere (40); the 31 E. coli genomes used for
designing the microarray included one urosepsis/pyelonephritis (CFT073), one
pyelonephritis (strain 536), four cystitis (F11, IAI39, UMN026, and UTI89), and
two ABU (VR50 and 83972) strains, as well as other pathogenic E. coli strains
(such as avian pathogenic E. coli [APEC] and enterohemorrhagic E. coli
[EHEC]) and a number of K-12 isolates. Of the 31 strains, 6, 8, 11, and 3
belonged to the phylogenetic groups A, B1, B2, and D, respectively. The mi-
croarray consisted of 134,285 probe sets (of 50- to 75-mers) representing 16,098
E. coli target genes. The genomic DNA was isolated using the Illustra bacterial
genomic Prep Spin Kit (GE Healthcare; 28-9042-58), and the samples were
diluted to the recommended concentration. Sample preparation was then carried
out using the NimbleGen Arrays User’s Guide for CGH analysis. All isolates,
except the reference strains CFT073 and 83972, were run as single samples.
CGH data analysis. Data analysis was performed in R (statistical software),
using the “oligo” package for analysis of oligonucleotide arrays at the probe level
(Bioconductor) (9). The RMA algorithm was used to perform background sub-
traction, normalization, and expression calculation (with output on the log2
scale). BLAST atlases were created using the GeneWiz whole-genome visual-
ization tool (31). Hierarchical agglomerative clustering was performed in R,
using the “hclust” clustering method, a Euclidean distance measure, and the
complete genomic profile of each strain (log values for all genes represented by
four or more probes). For interpretation of the CGH data, the following cutoff
values (log) were selected for presence/absence calls of the individual probes: log
values of 6 to 8 were considered negative, 8 to 10 borderline/unknown, and 10 to
12 positive. The cutoff values were selected based on comparison of the CGH
data obtained for CFT073 (run in triplicate) and the known genome sequence of
the strain.
PCR analysis. The microarray data were verified by PCR amplification using
primers targeting genes located upstream and downstream of pathogenicity
island (PAI)-CFT073-serU.
Phylogenetic group determination. For identification of phylogenetic group
associations, the rapid triplex PCR method was employed, using primers
targeting two genes (chuA and yjaA) and one anonymous DNA fragment
(TspE4.C) (4).
Statistical analysis. Statistical analysis was performed mainly by use of Fish-
er’s exact test. For multigroup comparisons, a 4-group Fisher’s exact test was
performed. For upper versus lower UTI comparisons, the prevalence data ob-
tained for the urosepsis and pyelonephritis isolates were compared with the data
obtained for the cystitis and ABU isolates; P values of  0.05 were considered
significant.
Yeast agglutination and hemagglutination tests. The presence of type 1
fimbriae was assayed by the ability of the bacteria to agglutinate yeast (Saccha-
romyces cerevisiae) cells on glass slides. Ten microliters of fresh overnight cul-
tures was mixed with 10 l 5% yeast cells. The experiment was repeated after the
cells had been washed and resuspended in LB containing 50 mM methyl--D-
mannopyranoside.
The capacity of bacteria to express P fimbriae was assayed by hemagglutination
with human type A red blood cells (RBCs). The RBCs were washed twice with
phosphate-buffered saline (PBS), and 10 l of 5% RBCs was mixed with a single
bacterial colony (freshly grown on LB plates) suspended in PBS on glass slides.
Any strain showing positive hemagglutination was tested again after 30 min of
incubation with 1% D-mannose to rule out type 1 fimbriae and to further support
the notion that agglutination was likely mediated by P fimbriae.
Motility on urine plates. One microliter of overnight culture was stabbed into
urine plates (pooled human urine) containing 0.3% agar. The distance of mi-
gration (the diameter of the ring around the inoculation site) was measured after
16 h of incubation at 37°C. The assay was performed in duplicate and repeated
twice in different batches of urine.
Hemolytic activity on blood agar plates. Isolated colonies were spot inocu-
lated, and the production of hemolysin was detected by determining a zone of
lysis under each colony on tryptone soy agar plates with sheep blood (Oxoid
Deutschland GmbH) after overnight incubation of the tested strains.
Microarray data accession numbers. The supporting microarray data have
been deposited in ArrayExpress (http://www.ebi.ac.uk/arrayexpress) with the ac-
cession numbers E-MEXP-3089 and E-MTAB-212.
RESULTS
Genomic diversity among urinary tract isolates. Forty-three
E. coli strains were studied (12 ABU, 9 cystitis, 8 pyelonephri-
tis, and 14 urosepsis strains). For comparison we also included
three reference strains: CFT073, a pyelonephritis strain; 83972,
an ABU strain; and the closely related probiotic strain Nissle
1917. The phylogenetic distribution of these strains within each
disease category was as follows: ABU, 38% B2, 31% B1, 23%
D, and 8% A; cystitis, 45% B2, 11% B1, 33% D, and 11% A;
pyelonephritis, 67% B2, 11% B1, and 22% D; and urosepsis,
100% B2. CGH analysis of the 46 E. coli strains revealed that
they clustered into three major groups (Fig. 1). Group I and II
strains were predominantly from phylogenetic groups D and
B1, respectively. In contrast, all group III strains belonged to
phylogenetic group B2. The group III strains could be further
subdivided into four subgroups; notably, groups IIIb and IIId
contained a high proportion of urosepsis strains (100% and
71%, respectively).
Prevalence of genomic islands. CGH analysis provides a
powerful tool for studying the prevalence of genes associated
with genomic islands (GIs). The CFT073 genome was included
in the design of our microarray and thus acted as an excellent
reference for comparison of the UTI isolates. The GIs of the
highly virulent pyelonephritis strain CFT073 are very well char-
acterized (28, 29). In order to study the prevalence of CFT073-
associated GIs among the UTI isolates, the genomic profiles of
the isolates were compared with CFT073 with respect to
CFT073-associated probes. A permissive cutoff value for the
presence of an island (2/3 of the genes in an island predicted
to be present) was selected to allow for some cross-hybridiza-
tion between generic island elements, e.g., transposases and
integrases (summarized in Tables 2 and 3). Furthermore, the
genomic profiles were analyzed with the GeneWiz BLAST
atlas program, which was used to compare the inferred
genomic profile of each UTI isolate to the genomic sequence
of CFT073 (Fig. 2). The UTI isolates were compared with
respect to disease category, as well as phylogenetic group as-
sociation.
Several of the GIs, including PAI-CFT073-icdA, PAI-CFT073-
serU, PAI-CFT073-asnT, GI-CFT073-cobU, PAI-CFT073-metV,
PAI-CFT073-selC, and PAI-CFT073-pheU (Table 2 and Fig. 2),
were found to be significantly more associated with the urosepsis
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and pyelonephritis isolates than with the cystitis and ABU
isolates, suggesting that these islands are associated with highly
virulent UPEC strains. However, the majority of these islands
were also significantly linked to the phylogenetic group origin
(Table 3). Separate analysis of the B2 isolates revealed a sig-
nificantly greater prevalence of PAI-CFT073-serU and PAI-
CFT073-pheU among the urosepsis and pyelonephritis isolates
than among the cystitis and ABU isolates (Table 3). One is-
land, viz., PAI-CFT073-asnT, or the high-pathogenicity island
(HPI), was found in all B2 isolates. Arguably, this suggests that
the island was acquired early in the evolution of the lineage
(Table 3). Most sequenced B2 strains, including the two com-
mensal isolates SE15 and ED1a, also carry this island. How-
ever, the HPI is not restricted to group B2; it was found, in
particular, among the group D isolates and in one of the two
group A isolates. Another island, PAI-CFT073-metV, was also
present in all but one of the group B2 isolates (cystitis isolate
VR158). PAI-CFT073-metV has previously been shown to con-
tribute to upper urinary tract infection (in a mouse model), an
activity shown to be associated with the last six genes in the
island (28). In fact, although VR158 was predicted to lack the
majority of the island (resulting in an overall absence call),
the strain contained five of these genes (c3405 to c3409;
c3410 was not on the microarray). The B2 commensal strain
SE15 also carries this island, and the other B2 commensal
strain, ED1a, carries the last six genes. Several islands were found
exclusively among the B2 UTI strains (as compared to the
sequenced non-UTI strains [see Fig. S3 in the supplemental
material]), i.e., PAI-CFT073-aspV, PAI-CFT073-serX,
PAI-CFT073-serU, GI-CFT073-asnW, GI-CFT073-selC, and
GI-CFT073-leuX. Two PAIs, PAI-CFT073-asnT and PAI-
CFT073-pheV, were particularly prevalent among the group D
strains (Table 3). The group A strains had very few islands;
only two islands were predicted to be present, i.e., PAI-
CFT073-asnT in ABU strain VR95 and GI-CFT073-cobU in
cystitis strain VR148. Although these strains may carry other
non-CFT073-like islands, it is possible that these islands con-
tribute to persistence in the urinary tract.
FIG. 1. Phylogenetic relationships between UTI isolates. (A) Phylogenetic group association based on the three group identifiers, chuA, yjaA,
and TspE4.C. The CGH data obtained three phylogenetic identifiers correlated with the PCR-based analysis, giving a perfect distribution into
phylogenetic groups. (B) Hierarchical clustering of the strains based on the whole-genome CGH profiles. Clustering was performed in R.
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Although the majority of the PAIs (63%) were more com-
monly associated with the urosepsis and pyelonephritis isolates
than with the cystitis and ABU strains, a considerable fraction
of the cystitis and ABU isolates contained multiple PAIs, and
none of these strains were completely devoid of genes from
these PAIs (Table 2). The average number of GIs per strain
decreased according to the severity of the infection caused by
the strain; urosepsis, pyelonephritis, cystitis, and ABU strains
carried on average 8.1, 6.4, 4.4, and 4.1 GIs per strain, respec-
tively. However, there was no significant difference between
the different disease categories within the same phylogenetic
group; in the B2 group, which contained strains from all four
disease categories, the urosepsis, pyelonephritis, cystitis, and
ABU isolates carried on average 8.1, 8.6, 6.3, and 7.4 islands,
respectively. On the other hand, the two commensal strains in
the B2 group contained only 3.5 GIs per strain (Table 3). The
average number of islands present per strain from each phy-
logenetic group was 7.8, 3.6, 1.3, and 1.0 for groups B2, D, B1,
and A, respectively. Altogether, although the number of GIs is
significantly higher in a UTI strain than in a commensal strain,
our results suggest that the number of GIs present in a UTI
strain is linked to the phylogenetic group association rather
than to the disease category.
Distribution of genes encoding virulence and fitness factors.
We then constructed a heat map based on 509 genes that
encode factors that have been shown to be involved in the
virulence and/or fitness of UPEC and ExPEC strains, as well as
putative virulence/fitness factors (Fig. 3). The CGH data ob-
tained for these factors clustered the B2 strains separately,
while another subgroup contained only D strains (group I); the
remaining subgroup contained all B1 and A strains, as well as
one D strain (group II) (Fig. 3). The isolates belonging to
group A, B1, and D possessed fewer virulence/fitness genes
than the B2 strains, in particular, the subgroup with B1 and A
strains (group II). This observation fits with the notion that a
high proportion of B2 isolates are more virulent, simply be-
cause they possess a high proportion of virulence/fitness fac-
tors. For the majority of the virulence/fitness genes, the ABU
and cystitis isolates belonging to B2 showed virulence gene
profiles very similar to those of the virulent isolates. The B2
isolates could be split into two subgroups, groups III and IV
(Fig. 3), where group III contains fewer virulence/fitness fac-
tors than group IV. Interestingly, both B2 groups III and IV
contain strains from all four disease categories and approxi-
mately the same proportion of urosepsis and ABU isolates, i.e.,
56% and 45% urosepsis and 22% and 11% ABU strains in
groups III and IV, respectively. This suggests that the number
of virulence/fitness factors per se cannot determine the patho-
genic potential of a UTI strain.
Since there was a clear correlation between the numbers of
PAIs and virulence/fitness factors and the phylogenetic group
origin, we treated each phylogenetic group separately when
screening for virulence/fitness factors specific to each disease
category. Due to the low number of isolates in groups B1 and
A, no statistically significant results were obtained for these
groups. Among the B2 isolates, 33 probes showed significantly
different prevalences among the four disease categories or
among upper versus lower UTIs (see Table S1 in the supple-
mental material). A third of these probes were pap operon
genes representing all pap genes encoding P fimbriae with the
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exception of papA, encoding the major subunit. P fimbriae
have previously been shown to be important for UTI coloni-
zation, and the cognate receptor is abundant in the kidneys
(reviewed in reference 21). This correlated well with pheno-
typic data, where only one cystitis and none of the ABU iso-
lates agglutinated red blood cells while the majority of the
pyelonephritis and urosepsis isolates did (Table 1). Four
probes specific for phosphoglycerate transport genes (pgt) were
also identified; these were particularly predominant in the uro-
sepsis isolates. Interestingly, in CFT073, the pgt operon is lo-
cated on PAI-CFT073-pheU, which also carries one of the two
pap operons present in CFT073. Whether the pgt genes confer
any virulence properties is unknown. Other probes differen-
tially distributed and associated with upper UTI included two
probes specific for the antigen 43 (Ag43) gene, which encodes
an autotransporter protein that contributes to long-term colo-
nization of the urinary tract (38). Six probes were significantly
associated with cystitis and ABU isolates; they included genetic
variants of fimA and kpsU, encoding the major subunit of type
1 fimbriae and a capsular protein, respectively. (Due to genetic
divergence between the genomes for these genes, representa-
tives of each genetic variant were included on the CGH mi-
croarray.) This suggests that antigenic and perhaps functional
variations between important surface structures, such as type 1
fimbriae and capsule, may underlie the differences observed
between the isolates. The ibeA gene, encoding a protein asso-
ciated with invasion by newborn meningitis-causing E. coli (15)
and identified as a virulence factor in avian-pathogenic E. coli
(10), was also positively associated with lower rather than up-
per UTI (see Table S1 in the supplemental material).
Among the group D isolates, 34 probes were identified that
displayed a significantly different distribution among the three
disease groups (no urosepsis strains belonged to group D).
Five of these 34 probes were more strongly associated with
pyelonephritis and cystitis isolates than with ABU isolates
(three probes specific for the ybg fimbrial operon and two
probes specific for genes that encode hypothetical proteins).
On the other hand, 29 of the 34 probes were more strongly
associated with ABU isolates than with pyelonephritis or
cystitis isolates; these included several fimbrial genes: the
ycbRSTU, yadKMN, and yfcQRSUV genes (see Table S1 in the
supplemental material). Interestingly, the ycb and yad fimbrial
operons have been implicated in biofilm formation, while the
yfc operon genes have been shown to confer adherence to T24
bladder epithelial cells (24).
UTI-specific and phylogenetic group-specific genes. The is-
sue of UTI-specific genetic markers has received considerable
attention over the years, and several attempts to identify
UPEC-specific genes have been made. Using a bioinformatics
approach, Chen et al. identified 29 genes that were subjected
to positive selection among UPEC strains (3). Furthermore,
using a CGH approach, Lloyd et al. identified 131 genes that
were present in all UPEC strains but not in any of the fecal or
commensal strains examined (29). Since both of these studies
focused entirely on virulent UTI isolates, it was not clear if any
of these genes were restricted to pathogens or prevalent among
UTI isolates in general. We assessed our CGH data to test for
a possible correlation between the UTI categories and the
prevalence of these UPEC-specific genes.
Based on the 29 genes identified by Chen et al., the isolates
T
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FIG. 2. Atlases generated using BLAST to compare the inferred genomic sequences of the 45 UTI isolates to CFT073, based on their disease
categories (A) and phylogenetic groups (B). The strains were as follows: (A) B2A, B3, B6, B8, B18, B20, B26, B30, B31, B34, B37, B39, B40, B41,
CFT073, VR150, VR151, VR152, VR153, VR154, VR155, VR156, VR157, VR145, VR146, VR147, VR148, VR149, VR158, VR159, VR160,
VR161, VR1, VR11, VR12, VR89, VR90, VR91, VR92, VR94, VR95, VR96, VR135, VR136, and VR137; and (B) B2A, B3, B6, B8, B18, B20,
B26, B30, B31, B34, B37, B39, B40, B41, CFT073, VR150, VR151, VR153, VR156, VR157, VR145, VR146, VR158, VR159, VR1, VR11, VR94,
VR135, VR136, VR154, VR155, VR147, VR149, VR160, VR89, VR90, VR137, VR152, VR161, VR12, VR91, VR92, VR96, VR148, and VR95.
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grouped almost entirely according to their phylogenetic groups,
with little or no correlation with their disease categories; all B2
strains and D strains clustered in one group each, and the third
group contained all B1 and A strains (see Fig. S1 in the sup-
plemental material). A similar trend, although not as pro-
nounced, was seen when examining the prevalence of the 131
genes identified by Lloyd et al.; while the B2 isolates grouped
separately, the remaining phylogenetic groups were less segre-
gated. Here, three group D ABU strains clustered with the B2
isolates instead of with the other D, A, and B1 isolates. No
clear delineation between disease categories was apparent (see
Fig. S2 in the supplemental material). The 131 genes were
particularly prevalent among the B2 strains; this was also
clearly reflected in the clustering of our 45 isolates (see Fig. S2
in the supplemental material). No genes that were uniformly
present in the 45 UTI isolates examined in this study were
absent in all six non-ExPEC sequenced strains. The same was
true when we focused only on the isolates that caused symp-
tomatic UTI. This supports the notion that uropathogenesis
and urinary tract infectivity are multifactorial traits.
Fitness factors. By virtue of their avirulent nature and their
ability to colonize the urinary tract and grow in urine, ABU
strains must possess fitness factors rather than virulence fac-
tors. To search for fitness factor-encoding genes, we compared
the inferred genomic contents of ABU isolates from phyloge-
netic groups A and B1 with six sequenced nonpathogenic non-
UTI E. coli commensal strains, including the prototypic K-12
strain MG1655. No genes shared among the ABU isolates of
the two groups were absent in the six strains used for compar-
ison. However, each individual isolate was found to carry nu-
FIG. 3. Heat map of the 45 UTI isolates constructed based on the CGH signals obtained for 509 established and putative virulence and fitness
factors of ExPEC strains.
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merous genes that were not present in the commensal isolates,
clearly signifying that the ABU strains are genetically diverse.
Genes present in some ABU isolates included several iron-
scavenging genes, as well as the pco genes involved in copper
resistance. We also screened for genes shared by all ABU
isolates within phylogenetic group B1. This analysis identified
six genes, which were all related to propanediol utilization
(pdu); the exact role of these genes in E. coli is unknown, but
in Salmonella enterica serovar Typhimurium, the pdu genes
have been implicated in fitness during in vivo infection (5).
There was only one ABU strain that belonged to phyloge-
netic group A, i.e., VR95. This strain was compared directly to
the two commensal group A strains MG1655 and HS. In total,
91 probes were specific for VR95. Among these probes were
genes associated with HPI. The HPI genes are expressed
during in vivo growth of the ABU isolate 83972 (32). This
suggests that the HPI is a fitness island rather than a patho-
genicity island per se, a notion that is supported by the
presence of this island in the two B2 commensal isolates
(see Fig. S3 in the supplemental material). Interestingly,
genes of the HPI are induced during growth in urine in
another ABU group A isolate, viz., VR50, which shows high
resemblance to commensal isolates (12). In summary, all ABU
strains examined contained between one and nine of the
CFT073 islands or phage regions (on average, 4.1 per strain)
(Table 2), suggesting that fitness is acquired by compilation of
different genes and not by acquiring any specific set of genes.
Phenotypic characterization. Expression of functional fim-
briae has been shown to be important for colonization of the
different compartments of the urinary tract. In particular, three
UPEC class fimbriae have been identified; type 1 fimbriae,
encoded by the fim genes, which bind specifically to mannose
targets found on the surfaces of uroepithelial bladder cells
(41); P fimbriae, encoded by the pap genes, which bind to
the -D-galactopyranosyl-(1-4)--D-galactopyranoside recep-
tor epitope in the globoseries of glycolipids of the upper uri-
nary tract (18, 26); and F1C fimbriae, encoded by the foc genes,
which bind to galactosylceramide targets present on epithelial
cells in the bladder and kidneys, as well as globotriaosylcer-
amide, present exclusively in the kidneys (2, 20). The different
binding patterns of these three fimbriae correlated well with
the presence of fimbrial gene clusters among the disease cat-
egories. The fim genes were present in the majority of strains
in all four disease categories; 93%, 100%, 100%, and 77% of
the urosepsis, pyelonephritis, cystitis, and ABU strains car-
ried the fim genes, respectively. While all of the urosepsis
and pyelonephritis strains carrying the fim genes expressed
functional type 1 fimbriae as assessed by yeast cell agglutina-
tion, three and two of the cystitis and ABU strains, respec-
tively, contained the fim genes but failed to express the phe-
notype (Table 1). All four phylogenetic groups contained
strains not expressing type 1 fimbriae. Furthermore, three
ABU strains and one urosepsis isolate were predicted to carry
eroded fim clusters. They included two B2 isolates, i.e., the
ABU strain 83972 and the urosepsis strain B3, which were both
predicted to lack the same fim genes, namely, fimEAIC. This
4.5-kb deletion has been verified by sequencing of the fim
cluster of 83972 (23).
The pap genes were present in 86%, 78%, 22%, and 15% of
the urosepsis, pyelonephritis, cystitis, and ABU strains, respec-
tively. While all the pyelonephritis isolates carrying the pap
genes agglutinated human RBCs, two of the urosepsis isolates
failed to express the phenotype. Of the two cystitis isolates
predicted to carry all pap genes (both from group D), only one
expressed the phenotype. Two ABU strains, one group B2
(strain 83972) and one group D (VR137) isolate, contained the
pap genes; only VR137 agglutinated RBCs. Strain 83972 is
known to carry point mutations in the papG gene rendering it
incapable of producing functional P fimbriae (23). Overall,
only group B2 and D strains expressed the phenotype; none of
the A strains and only one B1 strain contained the pap genes.
The foc genes, encoding F1C fimbriae, were present in 33 to
44% of all four disease groups. All 18 strains that contained the
foc genes were B2 isolates (Table 1), which corresponds to
62% of the B2 isolates.
Motility and hemolysis of RBCs are two other phenotypes
often associated with UPEC. All of the pyelonephritis isolates
and 89% of the cystitis isolates were motile; in contrast only
64% of the urosepsis and 46% of the ABU isolates were motile
(Table 1). The ability to cause hemolysis of RBCs was variable
and decreased according to disease severity: 57%, 56%, 33%,
and 15% of the urosepsis, pyelonephritis, cystitis, and ABU
isolates, respectively (Table 1). All hemolysis-positive strains
were B2 isolates.
In summary, the ABU isolates contained the lowest propor-
tion of strains that showed functional type 1 and P fimbriae,
motility on human urine plates, and hemolytic activity. The
highest proportion of strains expressing functional type 1 and
P fimbriae and displaying motility in urine were found among
the pyelonephritis strains, while hemolytic activity was seen at
a similar prevalence among sepsis and pyelonephritis isolates.
Hemolysis was clearly associated with isolates of phylogenetic
group B2.
DISCUSSION
The E. coli genome is undergoing constant evolution and
reflects the interplay between environmental selection pres-
sure and gene content. Gene acquisition and gene loss are the
key factors in genome evolution and are involved in the for-
mation of new strains. It is important to note that the urinary
tract is normally sterile and introduction of bacteria is “acci-
dental.” Infectious strains are generally believed to originate
from the fecal flora. The environmental conditions in the in-
testines and the urinary tract are quite different; arguably, they
impose different selection pressures on the bacteria. Thus, the
evolution of UPEC is not driven by a requirement to cause
disease but rather by a trade-off between environmental re-
quirements in a particular niche and the genetic composition
of the bacterial strain. E. coli strains acquire new genetic in-
formation via horizontal gene transfer, often in the form of
plasmids or GIs. A subgroup of GIs is termed PAIs because,
when identified, they were found to harbor virulence-associ-
ated genes (11). Likewise, loss of genetic information can oc-
cur via loss of plasmids or GIs, but also by smaller genetic
lesions, like point mutations. A classic example is the ABU
strain 83972, which is a deconstructed pathogen with an an-
cestor that closely resembled the bona fide pyelonephritis
strain CFT073 (22, 40).
In this study, we used a multigenome CGH microarray for a
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comparative genomics study of 45 E. coli strains isolated from
four different types of urinary tract infections. The major ad-
vantage of this approach was that a 31 E. coli strain large
pangenome was represented on the microarray, significantly
improving the application range of the array. The microarray
included probes representing all four UTI disease categories
employed in this study, i.e., the genomes of one urosepsis/
pyelonephritis, one pyelonephritis, four cystitis, and two ABU
strains were included in the microarray design (40). This al-
lowed us to estimate the genomic contents of the UTI strains
and the genetic variations among the strains. An inherent
limitation of the microarray is that novel genes, or genes that
are too heterologous, cannot be detected. It should also be
noted that our analysis did not take plasmid-borne genes into
account. Therefore, the possibility that plasmid-specific viru-
lence or fitness genes could have increased the discriminating
power of the data cannot be excluded.
From our CGH analysis, it was apparent that the single most
important determinant for the UTI isolates was their phyloge-
netic group origin. Generally, the data suggested that the B2
strains represent a highly virulent lineage of isolates that are
genotypically distinct from the other phylogenetic groups. Al-
though horizontally acquired genetic elements in general did
not disrupt the clonal structure of the species, the group A
strains did not cluster separately from the B1 and D groups.
No clear differences between symptomatic and ABU isolates
were apparent. We did, however, find a significant correlation
between disease severity and certain PAIs. Thus, PAI-CFT073-
serU and PAI-CFT073-pheU were found to be significantly
more associated with the urosepsis and pyelonephritis iso-
lates than with the cystitis and ABU isolates independent of
phylogenetic group origin. One island, PAI-CFT073-metV,
was found exclusively in B2 isolates. This island has previously
been reported to contribute to upper UTI due to at least six
genes on the island (28). The average number of PAIs was
significantly higher among the group B2 isolates (7.8 PAIs
compared with 1.0 to 3.6 PAIs for groups A, B1, and D), while
no correlation between the number of PAIs and disease sever-
ity was apparent within group B2 (6.3 to 8.6 PAIs for all four
disease categories). However, the commensal B2 isolates car-
ried an average number of PAIs that was significantly lower
(3.5 PAIs) than for strains in any of the disease categories,
indicating that specific genes are required for colonization of
the urinary tract but that the severity of disease might be
impossible to predict by estimating the number of virulence/
fitness genes carried by the strain.
A picture of the genetic profiles of different classes of UTI
strains is slowly emerging. In this study, the most virulent
strains (which belonged to phylogenetic group B2) generally
had the most virulence factors. Despite this, no specific con-
stellation of virulence factors was found in the most virulent
strains. Rather, an assortment of factors was associated with
high virulence. This assortment of genes included those encod-
ing adhesins, iron uptake systems, toxins, capsule, and flagella.
A similar picture emerged regarding fitness factors. Arguably,
ABU strains that are nonpathogenic yet grow well in urine and
colonize the urinary tract should have urinary tract-related
fitness factors compared with commensal gut isolates. We
found that the genes residing on the HPI genomic island could
be associated with fitness genes rather than virulence. Further-
more, genes involved in iron acquisition seem to be obligatory
for urinary tract fitness. However, as in the case of virulence
factors, it appeared that urinary tract fitness is acquired through
an assortment of genes rather than through a specific gene set.
Previous studies have suggested that many ABU strains have
lost critical virulence determinants or show reduced expression
of such genes (13, 32). We note that this study did not involve
a detailed phenotypic analysis of the strains or take into ac-
count the immune status of the infected patient. Individual
patient parameters, including immune status, could, for exam-
ple, contribute to ABU. Taken together, our study supports the
notion that urovirulence and fitness factors can be a mixture of
factors taken from a rich menu of genes.
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